While we're at it, here are a few more acquisitions that should happen right now.

Mylan's deal to buy Perrigo is taking another potential target off the block.

Teva, Actavis and other generics giants may start preying on each other.

With the recent deal for DAVA, Endo is now one of the best health care stocks to own.

These heavily shorted stocks could get squeezed on any positive catalyst.

"Overall supply constraints began to ease slightly at the back half of the fourth quarter and continuing into the start of the first quarter," said CEO Chuck Robbins.

A Russian citizen is charged in the U.S. for his alleged role in an international cryptocurrency money laundering conspiracy.

Sin City looks set to welcome another massive resort/casino that's going to compete with industry leaders Caesars and MGM.

The S&P 500 index has jumped 11% in the past month, 'reducing the general attraction of equities,' investor Doug Kass says.